Vorapaxar D5
| Product Name | Vorapaxar D5 |
|---|---|
| Alternate Names | Vorapaxar Stable Isotopes, Stable Isotopes of Vorapaxar |
| CAT No. | CS-O-15171 |
| CAS No. | 618385-01-6(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 497.61 g/mol |
| Mol. For. | C29H28D5FN2O4 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Vorapaxar |
| Purity | >98% |
| Smileys | C[C@@H](O1)[C@@]2([H])[C@H]([C@@](CC[C@@H](NC(OC([2H])([2H])C([2H])([2H])[2H])=O)C3)([H])[C@]3([H])C[C@@]2([H])C1=O)/C=C/C4=CC=C(C5=CC(F)=CC=C5)C=N4 |
| Canonical Smiles | CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C |
| InchIKey | ZBGXUVOIWDMMJE-QHNZEKIYSA-N |
| Inchl | InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1 |
| IUPAC | ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Vorapaxar D5 is a chemical compound that belongs to the class of antiplatelet agents. It works by inhibiting the protease-activated receptor-1 (PAR-1) which is responsible for the activation of platelets. Thus, Vorapaxar D5 is used to prevent blood clots in individuals who are at risk of cardiovascular events such as heart attack, stroke, or peripheral arterial disease. Vorapaxar D5 is administered orally as a tablet and is usually taken once daily.
Chemically, Vorapaxar D5 is known as (3R,4S)-4-(4-amino-3-chlorophenyl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-1-piperidinecarboxamide. Its molecular formula is C30H32ClN7O4 and its molecular weight is 603.08 g/mol.
It is important to note that Vorapaxar D5 is contraindicated in individuals who have a history of bleeding disorders, stroke, or transient ischemic attack. Additionally, it may interact with other medications such as anticoagulants and antiplatelet agents, leading to an increased risk of bleeding. Therefore, individuals who are taking Vorapaxar D5 should inform their healthcare provider of any other medications they are taking. Overall, Vorapaxar D5 is a useful medication in preventing blood clots and reducing the risk of cardiovascular events in high-risk individuals.
Get an Instant Quote
Related Compounds
Vorapaxar D5 Sulfate |